Net clinical benefit of oral anticoagulants in Asian patients with atrial fibrillation based on a CHA2DS2-VASc score
Abstract Background This study was conducted to assess the net clinical benefit (NCB) for oral anticoagulant (OAC) in atrial fibrillation (AF) patients according to the CHA2DS2-VASc score. Methods Patients with AF were prospectively recruited in the COOL AF Thailand registry from 2014 to 2017. The i...
Main Authors: | Komsing Methavigul, Ply Chichareon, Ahthit Yindeengam, Rungroj Krittayaphong |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-12-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12872-023-03643-8 |
Similar Items
-
Efficacy of R2CHA2DS2-VA score for predicting thromboembolism in Thai patients with non-valvular atrial fibrillation
by: Komsing Methavigul, et al.
Published: (2021-11-01) -
Atrial fibrillation and CHA2DS2VASc score of 1 - is there a problem in clinical practice?
by: E. I. Baranova, et al.
Published: (2020-04-01) -
CHA2DS2‐VASc Score and the Risk of Ventricular Tachyarrhythmic Events and Mortality in MADIT‐CRT
by: Eyal Nof, et al.
Published: (2020-01-01) -
The CHA2DS2-VASc score and in-hospital mortality in patients with COVID-19: A multicenter retrospective cohort study
by: Alaa Quisi, et al.
Published: (2020-10-01) -
The relationship of the serum endocan level with the CHA2DS2-VASc score in patients with paroxysmal atrial fibrillation
by: Gökhan Ceyhun
Published: (2021-01-01)